Arcturus Therapeutics Holdings Inc
ARCT
Market Cap$714.13M
Close$
$-27.74
201.6% downside
Current Fair Value
201.6% downsideOvervalued by 201.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $714.13 Million |
|---|---|
| Enterprise Value | $448.03 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.12 |
| Beta | 1.8 |
| Outstanding Shares | 26,928,041 |
| Avg 30 Day Volume | 513,060 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -24.02 |
|---|---|
| PEG | 21.85 |
| Price to Sales | 4.55 |
| Price to Book Ratio | 2.73 |
| Enterprise Value to Revenue | 2.69 |
| Enterprise Value to EBIT | -5.73 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
ESG Score
No data